CCAAT/Enhancer binding protein β regulates prostaglandin E synthase expression and prostaglandin E2 production in activated microglial cells

GLIA

Volumn 61, Issue 10, 2013, Pages 1607-1619

  Straccia, Marco ^a,b   Dentesano, Guido ^b   Valente, Tony ^a   Pulido Salgado, Marta ^a   Solà, Carme ^b   Saura, Josep ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INST D INVESTIGACIONS B   (Spain)

Author keywords

C EBP; COX 2; Glial activation; Microglia; Neuroinflammation; Prostaglandin E 2; PTGES

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; CYCLOOXYGENASE 2; GAMMA INTERFERON; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E SYNTHASE; PROSTAGLANDIN E2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; BINDING SITE; BRAIN CORTEX; CELL ACTIVATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; EMBRYO; GENOTYPE; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; MALE; MICROGLIA; MOUSE; NERVE CELL CULTURE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION SITE;

C/EBP; COX-2; GLIAL ACTIVATION; MICROGLIA; NEUROINFLAMMATION; PROSTAGLANDIN E 2; PTGES;

ANALYSIS OF VARIANCE; ANIMALS; CCAAT-BINDING FACTOR; CELLS, CULTURED; CEREBRAL CORTEX; CYCLOOXYGENASE 2; DINOPROSTONE; EMBRYO, MAMMALIAN; GENE EXPRESSION REGULATION; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; INTERFERON-GAMMA; INTRAMOLECULAR OXIDOREDUCTASES; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUROGLIA; PROTEIN BINDING; RNA, MESSENGER;

EID: 84882870599     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22542     Document Type: Article

References (54)

1. Ackerman WET, Summerfield TL, Vandre DD, Robinson JM, Kniss DA. 2008. Nuclear factor-kappa B regulates inducible prostaglandin E synthase expression in human amnion mesenchymal cells. Biol Reprod 78:68-76.
2. Ajmone-Cat MA, Nicolini A, Minghetti L. 2003. Prolonged exposure of microglia to lipopolysaccharide modifies the intracellular signaling pathways and selectively promotes prostaglandin E2 synthesis. J Neurochem 87:1193-1203.
3. Aktan S, Aykut C, Ercan S. 1991. Leukotriene C4 and prostaglandin E2 activities in the serum and cerebrospinal fluid during acute cerebral ischemia. Prostaglandins Leukot Essent Fatty Acids 43:247-249.
4. Almer G, Teismann P, Stevic Z, Halaschek-Wiener J, Deecke L, Kostic V, Przedborski S. 2002. Increased levels of the pro-inflammatory prostaglandin PGE2 in CSF from ALS patients. Neurology 58:1277-1279.
5. Andreasson K. 2010. Emerging roles of PGE2 receptors in models of neurological disease. Prostaglandins Other Lipid Mediat 91:104-112.
6. Baenziger NL, Becherer PR, Majerus PW. 1979. Characterization of prostacyclin synthesis in cultured human arterial smooth muscle cells, venous endothelial cells and skin fibroblasts. Cell 16:967-974.
7. Campuzano O, Castillo-Ruiz MM, Acarin L, Castellano B, Gonzalez B. 2008. Distinct pattern of microglial response, cyclooxygenase-2, and inducible nitric oxide synthase expression in the aged rat brain after excitotoxic damage. J Neurosci Res 86:3170-3183.
8. Candelario-Jalil E, Gonzalez-Falcon A, Garcia-Cabrera M, Alvarez D, Al-Dalain S, Martinez G, Leon OS, Springer JE. 2003. Assessment of the relative contribution of COX-1 and COX-2 isoforms to ischemia-induced oxidative damage and neurodegeneration following transient global cerebral ischemia. J Neurochem 86:545-555.
9. Chaudhry Ua, Zhuang H, Crain BJ, Doré S. 2008. Elevated microsomal prostaglandin-E synthase-1 in Alzheimer's disease. Alzheimers Dement 4:6-13.
10. Cheng Y, Wang M, Yu Y, Lawson J, Funk CD, Fitzgerald GA. 2006. Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function. J Clin Invest 116:1391-1399.
11. Choi S-H, Aid S, Bosetti F. 2009. The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: Implications for translational research. Trends Pharmacol Sci 30:174-181.
12. Cimino PJ, Keene CD, Breyer RM, Montine KS, Montine TJ. 2008. Therapeutic targets in prostaglandin E2 signaling for neurologic disease. Curr Med Chem 15:1863-1869.
13. Combrinck M, Williams J, De Berardinis MA, Warden D, Puopolo M, Smith AD, Minghetti L. 2006. Levels of CSF prostaglandin E2, cognitive decline, and survival in Alzheimer's disease. J Neurol Neurosurg Psychiatry 77:85-88.
14. Cortes-Canteli M, Luna-Medina R, Sanz-Sancristobal M, Alvarez-Barrientos A, Santos A, Perez-Castillo A. 2008. CCAAT/enhancer binding protein beta deficiency provides cerebral protection following excitotoxic injury. J Cell Sci 121:1224-1234.
15. de Oliveira ACP, Candelario-Jalil E, Bhatia HS, Lieb K, Hüll M, Fiebich BL. 2008. Regulation of prostaglandin E2 synthase expression in activated primary rat microglia: Evidence for uncoupled regulation of mPGES-1 and COX-2. Glia 56:844-855.
16. Diaz-Munoz MD, Osma-Garcia IC, Cacheiro-Llaguno C, Fresno M, Iniguez MA. 2010. Coordinated up-regulation of cyclooxygenase-2 and microsomal prostaglandin E synthase 1 transcription by nuclear factor kappa B and early growth response-1 in macrophages. Cell Signal 22:1427-1436.
17. Driver JA, Logroscino G, Lu L, Gaziano JM, Kurth T. 2011. Use of non-steroidal anti-inflammatory drugs and risk of Parkinson's disease: Nested case-control study. Br Med J 342:d198.
18. Ejarque-Ortiz A, Gresa-Arribas N, Straccia M, Mancera P, Sola C, Tusell JM, Serratosa J, Saura J. 2010. CCAAT/enhancer binding protein delta in microglial activation. J Neurosci Res 88:1113-1123.
19. Ejarque-Ortiz A, Medina MG, Tusell JM, Perez-Gonzalez AP, Serratosa J, Saura J. 2007. Upregulation of CCAAT/enhancer binding protein beta in activated astrocytes and microglia. Glia 55:178-188.
20. Healy ZR, Zhu F, Stull JD, Konstantopoulos K. 2008. Elucidation of the signaling network of COX-2 induction in sheared chondrocytes: COX-2 is induced via a Rac/MEKK1/MKK7/JNK2/c-Jun-C/EBPbeta-dependent pathway. Am J Physiol Cell Physiol 294:C1146-C1157.
21. Ikeda-Matsuo Y, Hirayama Y, Ota A, Uematsu S, Akira S, Sasaki Y. 2010. Microsomal prostaglandin E synthase-1 and cyclooxygenase-2 are both required for ischaemic excitotoxicity. Br J Pharmacol 159:1174-1186.
22. Ikeda-Matsuo Y, Ikegaya Y, Matsuki N, Uematsu S, Akira S, Sasaki Y. 2005. Microglia-specific expression of microsomal prostaglandin E2 synthase-1 contributes to lipopolysaccharide-induced prostaglandin E2 production. J Neurochem 94:1546-1558.
23. Jakobsson PJ, Thoren S, Morgenstern R, Samuelsson B. 1999. Identification of human prostaglandin E synthase: A microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc Natl Acad Sci USA 96:7220-7225.
24. Kapadia R, Tureyen K, Bowen KK, Kalluri H, Johnson PF, Vemuganti R. 2006. Decreased brain damage and curtailed inflammation in transcription factor CCAAT/enhancer binding protein beta knockout mice following transient focal cerebral ischemia. J Neurochem 98:1718-1731.
25. Kihara Y, Matsushita T, Kita Y, Uematsu S, Akira S, Kira J-i, Ishii S, Shimizu T. 2009. Targeted lipidomics reveals mPGES-1-PGE2 as a therapeutic target for multiple sclerosis. Proc Natl Acad Sci USA 106:21807-21812.
26. Koeberle A, Werz O. 2009. Inhibitors of the microsomal prostaglandin E(2) synthase-1 as alternative to non steroidal anti-inflammatory drugs (NSAIDs)-A critical review. Curr Med Chem 16:4274-4296.
27. Kutchera W, Jones DA, Matsunami N, Groden J, McIntyre TM, Zimmerman GA, White RL, Prescott SM. 1996. Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: Evidence for a transcriptional effect. Proc Natl Acad Sci USA 93:4816-4820.
28. Levi G, Minghetti L, Aloisi F. 1998. Regulation of prostanoid synthesis in microglial cells and effects of prostaglandin E2 on microglial functions. Biochimie 80:899-904.
29. Li W, Wu S, Hickey RW, Rose ME, Chen J, Graham SH. 2008. Neuronal cyclooxygenase-2 activity and prostaglandins PGE2, PGD2, and PGF2 alpha exacerbate hypoxic neuronal injury in neuron-enriched primary culture. Neurochem Res 33:490-499.
30. Liu Q, Inoue H, Mahendran R. 2008. Transcriptional regulation of the COX-2 expression by nitric oxide in colon cancer cell lines. Oncol Rep 19:269-274.
31. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408.
32. Mattsson N, Yaong M, Rosengren L, Blennow K, Mansson JE, Andersen O, Zetterberg H, Haghighi S, Zho I, Pratico D. 2009. Elevated cerebrospinal fluid levels of prostaglandin E2 and 15-(S)-hydroxyeicosatetraenoic acid in multiple sclerosis. J Intern Med 265:459-464.
33. Milatovic D, Montine TJ, Aschner M. 2011. Prostanoid signaling: dual role for prostaglandin E2 in neurotoxicity. Neurotoxicology 32:312-319.
34. Minghetti L, Pocchiari M. 2007. Cyclooxygenase-2, prostaglandin E2, and microglial activation in prion diseases. Int Rev Neurobiol 82:265-275.
35. Nakayama M, Uchimura K, Zhu RL, Nagayama T, Rose ME, Stetler Ra, Isakson PC, Chen J, Graham SH. 1998. Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia. Proc Natl Acad Sci USA 95:10954-10959.
36. Naraba H, Yokoyama C, Tago N, Murakami M, Kudo I, Fueki M, Oh-Ishi S, Tanabe T. 2002. Transcriptional regulation of the membrane-associated prostaglandin E2 synthase gene. Essential role of the transcription factor Egr-1. J Biol Chem 277:28601-28608.
37. Narumiya S, Sugimoto Y, Ushikubi F. 1999. Prostanoid receptors: structures, properties, and functions. Physiol Rev 79:1193-1226.
38. Saura J. 2007. Microglial cells in astroglial cultures: A cautionary note. J Neuroinflammation 4:26.
39. Saura J, Tusell JM, Serratosa J. 2003. High-yield isolation of murine microglia by mild trypsinization. Glia 44:183-189.
40. Screpanti I, Romani L, Musiani P, Modesti A, Fattori E, Lazzaro D, Sellitto C, Scarpa S, Bellavia D, Lattanzio G, Bistoni F, Frati L, Cortese R, Gulino A, Ciliberto G, Costantini F, Poli V. 1995. Lymphoproliferative disorder and imbalanced T-helper response in C/EBP beta-deficient mice. EMBO J 14:1932-1941.
41. Silva Bastos LF, Pinheiro de Oliveira AC, Magnus Schlachetzki JC, Fiebich BL. 2011. Minocycline reduces prostaglandin E synthase expression and 8-isoprostane formation in LPS-activated primary rat microglia. Immunopharmacol Immunotoxicol 33:576-580.
42. Straccia M, Gresa-Arribas N, Dentesano G, Ejarque-Ortiz A, Tusell JM, Serratosa J, Sola C, Saura J. 2011. Pro-inflammatory gene expression and neurotoxic effects of activated microglia are attenuated by absence of CCAAT/enhancer binding protein beta. J Neuroinflammation 8:156.
43. Takemiya T, Matsumura K, Sugiura H, Maehara M, Yasuda S, Uematsu S, Akira S, Yamagata K. 2010. Endothelial microsomal prostaglandin E synthase-1 exacerbates neuronal loss induced by kainate. J Neurosci Res 88:381-390.
44. Tanioka T, Nakatani Y, Semmyo N, Murakami M, Kudo I. 2000. Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis. J Biol Chem 275:32775-32782.
45. Tomimoto H, Akiguchi I, Wakita H, Lin JX, Budka H. 2000. Cyclooxygenase-2 is induced in microglia during chronic cerebral ischemia in humans. Acta Neuropathol 99:26-30.
46. Tsukada J, Yoshida Y, Kominato Y, Auron PE. 2011. The CCAAT/enhancer (C/EBP) family of basic-leucine zipper (bZIP) transcription factors is a multifaceted highly-regulated system for gene regulation. Cytokine 54:6-19.
47. Uematsu S, Matsumoto M, Takeda K, Akira S. 2002. Lipopolysaccharide-dependent prostaglandin E(2) production is regulated by the glutathione-dependent prostaglandin E(2) synthase gene induced by the Toll-like receptor 4/MyD88/NF-IL6 pathway. J Immunol 168:5811-5816.
48. Valente T, Straccia M, Gresa-Arribas N, Dentesano G, Tusell JM, Serratosa J, Mancera P, Sola C, Saura J. CCAAT/enhancer binding protein delta regulates glial proinflammatory gene expression. Neurobiol Aging 34:2110-24.
49. Vlad SC, Miller DR, Kowall NW, Felson DT. 2008. Protective effects of NSAIDs on the development of Alzheimer disease. Neurology 70:1672-1677.
50. Wadleigh DJ, Reddy ST, Kopp E, Ghosh S, Herschman HR. 2000. Transcriptional activation of the cyclooxygenase-2 gene in endotoxin-treated RAW 264.7 macrophages. J Biol Chem 275:6259-6266.
51. Whalley ET, Schilling L, Wahl M. 1989. Cerebrovascular effects of prostanoids: In-vitro studies in feline middle cerebral and basilar artery. Prostaglandins 38:625-634.
52. Wu KK. 2006. Transcription-based COX-2 inhibition: A therapeutic strategy. Thromb Haemost 96:417-422.
53. Yamagata K, Matsumura K, Inoue W, Shiraki T, Suzuki K, Yasuda S, Sugiura H, Cao C, Watanabe Y, Kobayashi S. 2001. Coexpression of microsomal-type prostaglandin E synthase with cyclooxygenase-2 in brain endothelial cells of rats during endotoxin-induced fever. J Neurosci 21:2669-2677.
54. Zhao Y, Usatyuk PV, Gorshkova IA, He D, Wang T, Moreno-Vinasco L, Geyh AS, Breysse PN, Samet JM, Spannhake EW and others. 2009. Regulation of COX-2 expression and IL-6 release by particulate matter in airway epithelial cells. Am J Respir Cell Mol Biol 40:19-30.